Loading...

CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC Management Changes 8-K Filing

CHRL

CRL

CHARLES RIVER LABORATORIES INTERNATIONAL INC

(CRL)

2025 8-K

Show Summary

Summary

Financial Statements

Share Purchases

Financial Results

Healthcare Conference

Credit Agreement Update

Q3 Financial Results

Earnings Reports

Shareholder Meeting

Earnings Reports

Earnings Reports

Appointment of Director

Management Change

Purchase of Shares

Financial Results for Q3 2023

Financial Results for Q2 2023

Annual Meeting of Shareholders

Earnings Report

Earnings Reports

External Links:

On May 20, 2025, Charles River Laboratories entered into an amendment extending CEO James Foster's employment until February 12, 2027. Additionally, the company held its Annual Shareholders Meeting on the same day, electing new directors and approving auditor appointments.

AI Assistant

CHARLES RIVER LABORATORIES INTERNATIONAL INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.